Literature DB >> 25732191

Inactivation of Protein Tyrosine Phosphatases Enhances Interferon Signaling in Pancreatic Islets.

William J Stanley1, Sara A Litwak2, Hong Sheng Quah1, Sih Min Tan3, Thomas W H Kay1, Tony Tiganis4, Judy B de Haan3, Helen E Thomas1, Esteban N Gurzov5.   

Abstract

Type 1 diabetes (T1D) is the result of an autoimmune assault against the insulin-producing pancreatic β-cells, where chronic local inflammation (insulitis) leads to β-cell destruction. T cells and macrophages infiltrate into islets early in T1D pathogenesis. These immune cells secrete cytokines that lead to the production of reactive oxygen species (ROS) and T-cell invasion and activation. Cytokine-signaling pathways are very tightly regulated by protein tyrosine phosphatases (PTPs) to prevent excessive activation. Here, we demonstrate that pancreata from NOD mice with islet infiltration have enhanced oxidation/inactivation of PTPs and STAT1 signaling compared with NOD mice that do not have insulitis. Inactivation of PTPs with sodium orthovanadate in human and rodent islets and β-cells leads to increased activation of interferon signaling and chemokine production mediated by STAT1 phosphorylation. Furthermore, this exacerbated STAT1 activation-induced cell death in islets was prevented by overexpression of the suppressor of cytokine signaling-1 or inactivation of the BH3-only protein Bim. Together our data provide a mechanism by which PTP inactivation induces signaling in pancreatic islets that results in increased expression of inflammatory genes and exacerbated insulitis.
© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25732191     DOI: 10.2337/db14-1575

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

Review 1.  Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes.

Authors:  Ashley R Burg; Hubert M Tse
Journal:  Antioxid Redox Signal       Date:  2017-11-27       Impact factor: 8.401

2.  Use of biologic or targeted-synthetic disease-modifying anti-rheumatic drugs and risk of diabetes treatment intensification in patients with rheumatoid arthritis and diabetes mellitus.

Authors:  Sarah K Chen; Hemin Lee; Yinzhu Jin; Jun Liu; Seoyoung C Kim
Journal:  Rheumatol Adv Pract       Date:  2020-06-22

3.  Star Polymers Reduce Islet Amyloid Polypeptide Toxicity via Accelerated Amyloid Aggregation.

Authors:  Emily H Pilkington; May Lai; Xinwei Ge; William J Stanley; Bo Wang; Miaoyi Wang; Aleksandr Kakinen; Marc-Antonie Sani; Michael R Whittaker; Esteban N Gurzov; Feng Ding; John F Quinn; Thomas P Davis; Pu Chun Ke
Journal:  Biomacromolecules       Date:  2017-10-31       Impact factor: 6.988

Review 4.  Cellular signaling pathways regulating β-cell proliferation as a promising therapeutic target in the treatment of diabetes.

Authors:  Wen-Juan Jiang; Yun-Chuan Peng; Kai-Ming Yang
Journal:  Exp Ther Med       Date:  2018-08-13       Impact factor: 2.447

5.  Whole-genome CRISPR screening identifies genetic manipulations to reduce immune rejection of stem cell-derived islets.

Authors:  Elad Sintov; Igor Nikolskiy; Victor Barrera; Jennifer Hyoje-Ryu Kenty; Alexander S Atkin; Dario Gerace; Shannan J Ho Sui; Kyle Boulanger; Douglas A Melton
Journal:  Stem Cell Reports       Date:  2022-09-01       Impact factor: 7.294

6.  Superoxide Production by NADPH Oxidase Intensifies Macrophage Antiviral Responses during Diabetogenic Coxsackievirus Infection.

Authors:  Ashley R Burg; Shaonli Das; Lindsey E Padgett; Zachary E Koenig; Hubert M Tse
Journal:  J Immunol       Date:  2017-11-20       Impact factor: 5.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.